Status:

UNKNOWN

Gene Expression Profiling in Subjects With Postoperative Atrial Fibrillation After Cardiac Surgery (GENEXPRO Surg)

Lead Sponsor:

Brigham and Women's Hospital

Conditions:

Atrial Fibrillation

Eligibility:

All Genders

20-99 years

Brief Summary

Atrial fibrillation is a type of irregular heartbeat that is common after having heart surgery. There may be many different reasons why some people get atrial fibrillation after their heart surgery. T...

Detailed Description

Atrial fibrillation is a type of irregular heartbeat that is common after having heart surgery. There may be many different reasons why some people get atrial fibrillation after their heart surgery. T...

Eligibility Criteria

Inclusion

  • Age 20-99 years
  • Undergoing cardiac surgery

Exclusion

  • Prior cardiac surgery
  • chest radiation
  • recent chemotherapy

Key Trial Info

Start Date :

August 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 1 2025

Estimated Enrollment :

350 Patients enrolled

Trial Details

Trial ID

NCT00833313

Start Date

August 1 2008

End Date

August 1 2025

Last Update

February 8 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115

Gene Expression Profiling in Subjects With Postoperative Atrial Fibrillation After Cardiac Surgery (GENEXPRO Surg) | DecenTrialz